Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|8|6|388-400

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.8, Iss.6, 2007-12, pp. : 388-400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 – 2013)

By Valente Sergio   Mai Antonello  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 401-415

Informa Healthcare

Access to resources Recommend Favorite

Progress in the Discovery of Macrocyclic Histone Deacetylase Inhibitors for the Treatment of Cancer

By  

Current Medicinal Chemistry, Vol. 24, Iss. 37, 2017-12 ,pp. : 4166-4179

Bentham Science Publishers

Access to resources Recommend Favorite

An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

By  

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 439-452

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future Prospects

By  

Current Cancer Drug Targets, Vol. 17, Iss. 5, 2017-05 ,pp. : 456-466

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: An Attractive Strategy for Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 20, Iss. 14, 2013-05 ,pp. : 1858-1886

Bentham Science Publishers

Access to resources Recommend Favorite